Gardner et al., Human Mutation 1 Supp. Figure S1

1 downloads 0 Views 874KB Size Report
RESCUE-ESE are shown above the genomic sequence of exon 3 for each .... bull's-eye maculopathy. Epiretinal. Central macular atrophy. Centra l well define d.
Gardner et al., Human Mutation

Supp. Figure S1. Cone dystrophy and colour blindness segregating with different cone opsin array haplotypes. Pedigree of Family 22 with segregation of X-linked cone dystrophy (filled symbols) and protanopia (shaded symbols). Segregation of the cone opsin array haplotypes is shown beneath each individual in the pedigree. Xlinked cone dystrophy segregates with haplotype p.C203R on one X-chromosome and protanopia segregates with a single M- gene on a different X-chromosome. Individual IV-7, unusually for a female, is colour blind and is a compound heterozygote for p.C203R and a single M- gene haplotype.

1

Gardner et al., Human Mutation

S10

S12

S2

S5

S17

S19

S20

S23

S21

S26

N

Supp. Figure S2. Electroretinogram traces for adult subjects. Subject ID is given on the left for each trace. DA refers to Dark Adapted; LA to Light Adapted; PERG to Pattern ERG. Supp. Table S1 provides further details.

2

Gardner et al., Human Mutation

3

Supp. Figure S3. Distribution of electroretinogram amplitudes by mutation class and patient. Full-field ERG amplitudes in 10 patients. Amplitudes are expressed as a percentage of the age-matched lower limit of normal and are shown for dark-adapted ERGs (DA0.01; DA010.0 a-wave) and light adapted ERGs (LA 3.0 30Hz; LA 3.0 b-wave). The genotype is stated for each subject. Lower limit of normal is defined as the minimum normal value minus 5% of the reference interval (maximum-minimum normal value in a group of healthy subjects).

Gardner et al., Human Mutation

4

150 ERG amplitude (% of age-matched normal)

LA 3.0 30Hz ERG

100

50

0

0

20

40 age (years)

60

80

Supp. Figure S4. Electroretinogram (ERG) amplitudes and patient age. Comparison of full-field ERG amplitudes (DA 10.0 ERG a-wave; LA 3.0 30Hz ERG) with age in 6 individuals with exon 3 interchange haplotypes. There is a trend for ERG amplitudes (corrected for age) to decrease with advancing age.

Gardner et al., Human Mutation

5

Supp. Figure S5. Serial electroretinograms (ERG) of patients S21 and S26. Comparison of fullfield ERG parameters at baseline with those at follow-up in S21 and S26. In S21 DA 0.01 and DA 10.0 a-wave amplitudes showed marked reduction in amplitude after 12 years. In S26 all amplitudes were reasonably stable but DA0.01 ERG showed an increase in peak time of 15ms bilaterally after an interval of 5 years.

Gardner et al., Human Mutation

6

Supp. Figure S6. Splicing motif prediction comparison for wild-type and disease associated L- and M- exon 3 haplotypes. (A) Splice enhancer motifs (yellow type) predicted by RESCUE-ESE are shown above the genomic sequence of exon 3 for each haplotype (shown to left of figure). The SNP c.532A>G results in loss of a splice enhancer motif (white arrow) in all 3 disease associated haplotypes LIAVA, LVAVA and MIAVA. (B) Splice silencer motifs (red type) predicted by FAS-ESS are shown above exon 3 genomic sequence. SNP c.532A>G results in the gain of a splice silencer motif (black arrow) in all three disease associated haplotypes while other SNPs in the haplotype have no predicted effect on splicing.

Gardner et al., Human Mutation

7

Supp. Table S1. Summary of clinical findings Mutation

LCR DEL

Subject Age (S)yrs Family (F) ID

S1 F1

10

Age of onset

Clinical

Refract ERG ion

LCR DEL

S2 F2

S3 F3

14

16

OCT

FAF

Visual Acuity

Poor vision from 5 yrs

HRR/Ishih ara plates Nystagmus

Poor vision from 3 mths

M +++

Cone ++++ Rod technically poor Mac ++++

Myopic

M +++

Cone++++ Rod + Mac ++++ S-cone normal

Myopic

Slight granular appearance to ellipsoid line centrally

ND

Seen once

M+

Cone ++++ Rod normal Mac ++++ S-cone absent

ND

ND

ND

No 5 yrs

6/30 BE

Nystagmus 6/36 BE Tri-3/4 Pro/deusome (abn deutan) Nystagmus

Poor vision from 18 6/38 RE mths 6/48 LE

Tri-4/4 Pro/deu - 0

Progression Test Interval

Tri -4/4 Pro/deu – 0 LCR DEL

Fundus appearance

Normal

ND

No 5 yrs

Gardner et al., Human Mutation Mutation

LCR DEL

LCR DEL

Subject Age (S)yrs Family (F) ID

S4 F4

S5 F5

17

58

Age of onset

8 Clinical

Refract ERG ion

Fundus appearance

OCT

FAF

Visual Acuity

Poor vision from infancy

Poor vision from infancy

HRR/Ishih ara plates Nystagmus

Test Interval

M+

ND

ND

ND

ND

6/30 RE 6/38 LE Trit-1/4 Pro/deu - 0 No documented Nystagmus

Progression

No 2 yrs

M +++

Cone +++ Peripapillary Rod normal atrophy Mac ++++

Disruption of central outer retinal layer

ND

ND

ND

ND

No 8 yrs

6/60 RE 6/48 LE

p.C203R

S6 F6

4

Poor vision from early infancy

Tri-3/4 Pro/deu - 0 Nystagmus 6/60 RE 6/48 LE

Colour testing ND

M ++

ND

No 4 yrs

Gardner et al., Human Mutation Mutation

p.C203R

p.C203R

Subject Age (S)yrs Family (F) ID

S7 F7

S8 F8

5

8

Age of onset

9 Clinical

Refract ERG ion

Fundus appearance

OCT

FAF

Visual Acuity

Poor vision from 6 mths

Poor vision from 5 yrs

HRR/Ishih ara plates Nystagmus 6/48 RE 6/38 LE Tritan-1/4 Pro/deu - 0 No documented Nystagmus

Progression Test Interval

Myopic astigma tism

Cone +++Rod normal Mac ND S-cone normal

Blond fundus

Normal

Norm al

No

M ++

Cone +++ Rod normal Mac ++++

ND

Myopic Astigm atism

Cone +++ Rod normal Mac ND

Normal

ND

ND

No 1 yr

Myopic Astigm atism

Cone ++++ Rod normal Mac ++++

Normal

Granular appearance to ellipsoid

ND

No

3 yrs

ND

ND

No 2 yrs

6/38 BE

p.C203R

p.C203R

S9 F9

S10 F10

11

14

Poor vision from early infancy Poor vision from

Tri-4/4 Pro/deusome Nystagmus 6/60 BE Tri-2/4 Pro/deu - 0 Nystagmus 6/19 RE

10 yrs

Gardner et al., Human Mutation Mutation

Subject Age (S)yrs Family (F) ID

Age of onset

S11 F11

16

Clinical

Refract ERG ion

Fundus appearance

OCT

FAF

Visual Acuity

early infancy

p.C203R

10

ND

Test Interval

HRR/Ishih ara plates 6/24 LE Tritan-3/4 Pro/deu9/20 Nystagmus

Progression

S-cone normal

line centrally

M+

Cone ++++ Rod normal

Peripheral Normal hyperpigment ation

ND

No 1 yr

M+

Cone +++ Rod + Mac +++ S-cone normal

Normal

Norm al

No

Cone +++ Rod normal

Bull’s- eye maculopathy, pigmentary changes,

6/60 BE Ishihara - 0

p.C203R

S12 F12

19

Poor vision from infancy

Nystagmus 6/36 BE Tri-4/4 Passed Berson Pro/deu-0

p.C203R

S13 F22

27

ND

Nystagmus 6/60 BE

M +++

Normal

2 yrs

ND

ND

No 7 yrs

Gardner et al., Human Mutation Mutation

Subject Age (S)yrs Family (F) ID

Age of onset

11 Clinical

Refract ERG ion

S14 F22

18

OCT

FAF

Visual Acuity

ND

Nystagmus

Progression Test Interval

HRR/Ishih ara plates Colour testing ND

p.C203R

Fundus appearance

thinning of retinal vessels M+++

Cone ++++ Rod +

Pale discs, mottled macular pigmentation

ND

ND

No

M+

Cone ++++ Rod ND

Macular atrophy

ND

ND

No

M +++

Cone++++ Rod normal

Peripapillary atrophy

Normal

ND

No

6/18 BE at 1 yr 6/36 BE at 5yrs Colour testing ND p.C203R

S15 F22

19

ND

Nystagmus 2/60 BE - at 3 yrs 3/60 RE 6/60 LE - at 4yrs

LIAVA LIAVA

S16 F14

10

ND

Pro/deu-0 No documented

Gardner et al., Human Mutation Mutation

Subject Age (S)yrs Family (F) ID

Age of onset

12 Clinical

Refract ERG ion

Fundus appearance

OCT

FAF

Visual Acuity

Test Interval

HRR/Ishih ara plates Nystagmus

MVVVA

Progression

Mac ++++

2 yrs

6/18 BE

LIAVA LIAVA MVVVA

S17 F15

18

Poor vision from early infancy

Tri - 4/4 Pro/deu some No documented Nystagmus

M +++

Cone ++ Rod normal Mac ++++ S-cone normal

Mild macular hyperpigmentation

Normal

Cone +++ Rod normal Mac +++ S-cones normal

Blond fundus

ND

Norm al

No 3 yrs

6/12 RE 6/18 LE

LVAVA

S18 F16

10

Poor vision from 9 mths

Tri-all Pro/deusome No documented Nystagmus 6/15 RE 6/12 LE

M ++

ND

No 1 yr

Gardner et al., Human Mutation Mutation

Subject Age (S)yrs Family (F) ID

Age of onset

13 Clinical

Refract ERG ion

Fundus appearance

OCT

FAF

Visual Acuity

Progression Test Interval

HRR/Ishih ara plates

LVAVA

S19 F13

40

Poor vision from 2 yrs

Tri-all Pro/deu- 0 No documented Nystagmus

M +++

6/24 BE

LVAVA

LIAVA

S20 F17

S21 F18

49

73

Poor vision from early infancy

Poor vision from early infancy

Tri-3/4 Pro/deu – 0 No documented Nystagmus

M +++

6/18 BE Tri-4/4 Pro/deu-0 No documented Nystagmus 6/60 BE

M +++

Cone +++ Rod ++ Mac ++++ S-cone normal

Moderate central macular atrophy, peripapillary atrophy

Central outer retinal atrophy

Norm al

Cone ++ Rod + Mac ++++ S cone normal

Peripapillary atrophy, mild macular hyperpigmention, pale optic discs

ND

Age 59 Cone ++++ Rod Normal Mac ++++ S-cone normal

Bilateral bull’s-eye maculopathy

Subfoveal lucency between ellipsoid and retinal pigment epithelial layers Central macular atrophy

Epiretinal

No 3 yrs

No 5 years

Centra l well define d macul ar

Yes 20 years Progression on ERG with

Gardner et al., Human Mutation Mutation

Subject Age (S)yrs Family (F) ID

Age of onset

14 Clinical

Refract ERG ion

LIAVA MIAVA* MIAVA*

S22 F19

S23 F19

9

68

OCT

FAF

Visual Acuity

Poor vision from infancy

Poor vision from infancy

Nystagmus

Progression Test Interval

HRR/Ishih ara plates Tri-0/4 Ishihara -0 Pro/deu-0

LIAVA MIAVA* MIAVA*

Fundus appearance

membranes

M +++

Age 71 Cone ++++ Rod ++ S-cone normal Cone ++++ Rod +

Peripapillary atrophy Myopic fundus

hypo- increasing autofl rod uoresc dysfunction ence

Myopic thinning

ND

Stable over 6 years

ND

Centra ND l hypoa utofluore scent region with hyper autofluore scent rim

6/36 BE Color testing ND Nystagmus 6/60 BE Tri-4/4 Pro/deusome

Mac and Scone ND M+

Cone ++++ Rod normal Mac ++++ S-cone absent

Bilateral macular atrophy, peripapillary atrophy

Gardner et al., Human Mutation Mutation

MIAVA MIAVA MVVVA

MIAVA MIAVA MVVVA

LVAVA LVAVA MVVVA

Subject Age (S)yrs Family (F) ID

S24 F20

S25 F20

S26 F21

34

51

80

Age of onset

15 Clinical

Refract ERG ion

Fundus appearance

OCT

FAF

Visual Acuity

Poor vision from 6 mths

HRR/Ishih ara plates Nystagmus

Poor vision in late 20s

Test Interval

M +++

6/24 BE

Colour testing ND Poor Nystagmus vision Bilateral from 12 ptosis mths convergent squint

M +++

-18.0 D BE at age 13

Colour testing ND No documented Nystagmus

M+

Colour testing ND

Cone ++ Rod technically poor

Peripapillary atrophy, mild inferior retinal pigmentation

ND

Cone +++ Rod +++

Severe myopic degeneration

ND

Progres sive

6/18 BE

6/36 BE

Progression

Cone +++ Rod + Mac ++++ S cones Normal

Normal

ND

No 2 yrs

ND

No 13 yrs

Disruption of outer retinal layer

Norm al

Maternal Grandfather (I-1) registered blind at 58yrs Yes Progression on ERGs, over 5 yrs, Rod peak time prolonged, cone system

Gardner et al., Human Mutation Mutation

Subject Age (S)yrs Family (F) ID

Age of onset

16 Clinical Visual Acuity

Refract ERG ion

Fundus appearance

OCT

FAF

Progression Test Interval

HRR/Ishih ara plates function unchanged LCR DEL = locus control region deletion, LIAVA represents haplotype (GCG/AT/c/G/G), MIAVA represents haplotype (AAC/AT/c/G/G) MIAVA* represents (AAG/AT/c/G/G), LVAVA represents haplotype (GCG/GG/c/G/G), MVVVA represents haplotype (AAC/GG/t/G/G). Visual acuity refers to Snellen visual acuity, RE is right eye, LE is left eye, BE both eyes; HRR refers to Hardy-Rand-Rittler colour plates that were seen; ERG is electroretinogram; OCT is Optical Coherence Tomography; FAF is fundus autofluorescence; ND, not determined. Myopia; + low (6 Diopters). Mac +, ++, +++ and ++++ refer to mild (70-99% of normal amplitude), moderate (30-69% of normal), severe (1-29% of normal) and undetectable macular dysfunction, respectively. Cone +, ++, +++ and ++++ refer to mild (70-99% of normal amplitude), moderate (30-69% of normal), severe (1-29% of normal) and undetectable cone system dysfunction, respectively. Rod +, ++, +++ and ++++ refer to mild (70-99% of normal amplitude), moderate (30-69% of normal), severe (1-29% of normal) and undetectable rod system dysfunction, respectively.

Gardner et al., Human Mutation

17

Supp. Table S2. Electroretinogram results in paediatric patients (surface recordings and paediatric protocol) Mutation

Subject Age at ERG (yrs)

Stimulus Scotopic bright flash ERG

Photopic 30Hz ERG

Pattern ERG (PERG)

LCR

S1

5

Strobe

Unreliable

Undetectable

Undetectable

LCR

S3

10

Ganzfeld

Normal

Undetectable

Undetectable

p.C203R

S7

3

Strobe

Normal

Severe

Not Done

p.C203R

S8

5

Ganzfeld

Normal

Severe

Undetectable

p.C203R

S11

14

Strobe

Normal

Undetectable

Not done

p.C203R

S14

2

Strobe

Mildly reduced

Undetectable

Not done

p.C203R

S15

4

Strobe

Not done

Undetectable

Not done

Interchange

S16

6

Ganzfeld

Normal

Undetectable

Undetectable

Interchange

S22

5

Strobe

Mildly reduced

Undetectable

Not done

Gardner et al., Human Mutation

18

Supp. Table S3. ISCEV Electroretinograms (ERG), pattern ERGs and S-cone ERGs in adults Mutation

Subject

Age (at ERG)

ISCEV ERG

ISCEV ERG

ISCEV ERG

(DA10.0)

(LA 3.0 30Hz)

S-cone ERG

ISCEV PERG

(DA 0.01)

LCR

S2

10

Mild

Mild

Undetectable

Normal

Undetectable

LCR

S5

52

Normal

Normal

Severe

Not available

Undetectable

p.C203R

S10

10

Normal

Normal

Undetectable

Normal

Undetectable

p.C203R

S12

16

Mild

Mild

Severe

Normal

Severe

Interchange

S17

16

Normal

Mild

Moderate

Normal

Undetectable

Interchange

S19

38

Moderate

Mild

Severe

Normal

Undetectable

Interchange

S20

44

Mild

Normal

Moderate

Normal

Undetectable

Interchange

S21

59

Normal

Normal

Undetectable

Normal

Undetectable

Interchange

S23

63

Normal

Normal

Undetectable

Undetectable

Undetectable

Interchange

S26

69

Mild

Moderate

Severe

Normal

Undetectable

ERG measures of dysfunction; Mild: 70%-99% of normal amplitude, Moderate 30-69% of normal, Severe 1-29% of normal, Undetectable. *6mm pupils ISCEV refers to International Society for Clinical Electrophysiology of Vision; DA to Dark Adapted; LA to Light Adapted.